50 results on '"Fanini, Francesca"'
Search Results
2. Dendritic cell vaccines as cancer treatment: focus on 13 years of manufacturing and quality control experience in advanced therapy medicinal products
3. Publisher Correction: Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs.
4. Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs.
5. Supplemental Figure 1 from Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers
6. Supplemental Figure 3 from Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers
7. Supplemental Figure 2 from Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers
8. Supplemental Figure 4 from Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers
9. Supplemental Figure 5 from Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers
10. Stability Program in Dendritic Cell Vaccines: A “Real-World” Experience in the Immuno-Gene Therapy Factory of Romagna Cancer Center
11. Strand-Specific miR-28-5p and miR-28-3p Have Distinct Effects in Colorectal Cancer Cells
12. Modulation of mismatch repair and genomic stability by miR-155
13. MicroRNA-16 Restores Sensitivity to Tyrosine Kinase Inhibitors and Outperforms MEK Inhibitors in KRAS-Mutated Non-Small Cell Lung Cancer
14. The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis
15. Safety and efficacy of anti-PD-1 inhibitors in Chinese patients with advanced lung cancer and hepatitis B virus infection: a retrospective single-center study
16. MicroRNAs and drug modulation in cancer: an intertwined new story
17. miR-9-5p as a Regulator of the Androgen Receptor Pathway in Breast Cancer Cell Lines
18. Tumorlets in Familial History of Bronchopulmonary Carcinoid
19. Association of a MicroRNA/TP53 Feedback Circuitry With Pathogenesis and Outcome of B-Cell Chronic Lymphocytic Leukemia
20. Microbiota-Derived Metabolites in Tumor Progression and Metastasis
21. Ki67 and PR in Patients Treated with CDK4/6 Inhibitors: A Real-World Experience
22. Presence of human papillomavirus DNA in breast cancer patients: SERUM and tissue analysis.
23. ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients
24. Enzymatic descemetic lamellar keratoplasty: pilot study
25. Epigenetics, miRNAs, and human cancer: a new chapter in human gene regulation
26. Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs (vol 8, 2017)
27. Corrigendum to “MicroRNAs as lung cancer biomarkers and key players in lung carcinogenesis” Clinical Biochemistry 46 (2013) 918–925
28. MicroRNAs and Androgen Receptor: Emerging Players in Breast Cancer
29. A miR-155/TP53 regulatory feedback loop involved in resistance to therapy in lung cancer and leukemia
30. Emerging roles of microRNAs in cancer
31. Cancer-derived exosomic microRNAs shape the immune system within the tumor microenvironment: State of the art
32. Prolonged Pemetrexed Infusion Plus Gemcitabine in Refractory Metastatic Colorectal Cancer: Preclinical Rationale and Phase II Study Results
33. Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers
34. A signature of ultraconserved regions (UCRs) harbors prognostic implications in clear cell renal cell carcinoma (ccRCC)
35. A Dendritic Cell (DC) microRNA signature predicts clinical outcome in Melanoma Patients treated with DC vaccine
36. Exosome-Mediated Transfer of microRNAs Within the Tumor Microenvironment and Neuroblastoma Resistance to Chemotherapy
37. The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis
38. MiR-30 Family Potentially Targeting PI3K-SIAH2 Predicted Interaction Network Represents a Novel Putative Theranostic Panel in Non-small Cell Lung Cancer.
39. MicroRNAs and dendritic cell-based vaccination in melanoma patients
40. microRNAs in the tumor microenvironment: solving the riddle for a better diagnostics
41. MicroRNAs as lung cancer biomarkers and key players in lung carcinogenesis
42. Clinical Implications of MicroRNAs in Lung Cancer
43. Abstract LB-347: A microRNA signature harbors prognostic implications in clear cell renal carcinoma (ccRC)
44. Enzymatic Descemetic Lamellar Keratoplasty: Pilot Study
45. MicroRNAs: tiny players with a big role in the pathogenesis of leukemias and lymphomas
46. ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients
47. Ki67 and PR in Patients Treated with CDK4/6 Inhibitors: A Real-World Experience
48. Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers
49. Prolonged Pemetrexed Infusion Plus Gemcitabine in Refractory Metastatic Colorectal Cancer: Preclinical Rationale and Phase II Study Results
50. Exosome-mediated transfer of microRNAs within the tumor microenvironment and neuroblastoma resistance to chemotherapy.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.